184 related articles for article (PubMed ID: 35276022)
1. Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Eze C; Friedrich I; Hadi I; Schmidt-Hegemann NS; Hartoyo SN; Trauth R; Reitz D; Manapov F; Siefert A; Dreyling M; Belka C; Li M
Eur J Haematol; 2022 Jul; 109(1):21-30. PubMed ID: 35276022
[TBL] [Abstract][Full Text] [Related]
2. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
3. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma.
Hata M; Omura M; Koike I; Tomita N; Iijima Y; Tayama Y; Odagiri K; Minagawa Y; Ogino I; Inoue T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1387-93. PubMed ID: 20950950
[TBL] [Abstract][Full Text] [Related]
4. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
Fang P; Gunther JR; Pinnix CC; Dong W; Strati P; Nastoupil LJ; Steiner RE; Ahmed S; Damron EP; Fowler N; Nair R; Westin JR; Neelapu S; Ha CS; Dabaja BS
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1414-1420. PubMed ID: 33309978
[TBL] [Abstract][Full Text] [Related]
7. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
8. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.
Bayraktar S; Bayraktar UD; Stefanovic A; Lossos IS
Br J Haematol; 2011 Jan; 152(1):72-80. PubMed ID: 21083656
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
10. Primary radiotherapy for localized orbital MALT lymphoma.
Le QT; Eulau SM; George TI; Hildebrand R; Warnke RA; Donaldson SS; Hoppe RT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):657-63. PubMed ID: 11849787
[TBL] [Abstract][Full Text] [Related]
11. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy.
Bischof M; Zierhut D; Neuhof D; Karagiozidis M; Treiber M; Roeder F; Debus J; Krempien R
Ophthalmologica; 2007; 221(5):348-52. PubMed ID: 17728558
[TBL] [Abstract][Full Text] [Related]
12. Curative radiotherapy for primary orbital lymphoma.
Bhatia S; Paulino AC; Buatti JM; Mayr NA; Wen BC
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):818-23. PubMed ID: 12377334
[TBL] [Abstract][Full Text] [Related]
13. Examining the utility of lower dose radiotherapy for localised primary ocular adnexal MALT lymphoma.
Leeson S; Jayamohan J; Vu H; Sundaresan P
J Med Radiat Sci; 2021 Sep; 68(3):269-273. PubMed ID: 33675287
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization.
Lee J; Yoon JS; Kim JS; Koom WS; Cho J; Suh CO
Jpn J Clin Oncol; 2019 Jul; 49(7):664-670. PubMed ID: 31505651
[TBL] [Abstract][Full Text] [Related]
15. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
16. Ocular adnexal MALTomas: case series of patients treated with primary radiation.
Russell W; Herskovic A; Gessert D; Cohen JA; Rubenstein JB; Gregory SA
Clin Adv Hematol Oncol; 2013 Apr; 11(4):209-14. PubMed ID: 23604236
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy.
Parikh RR; Moskowitz BK; Maher E; Della Rocca D; Della Rocca R; Culliney B; Shapira I; Grossbard ML; Harrison LB; Hu K
Leuk Lymphoma; 2015 May; 56(5):1266-70. PubMed ID: 25356924
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma.
Tran KH; Campbell BA; Fua T; MacManus M; Ryan G; Chesson B; Wirth A
Leuk Lymphoma; 2013 Mar; 54(3):491-6. PubMed ID: 23020137
[TBL] [Abstract][Full Text] [Related]
20. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]